Capramol en es it fr

Capramol Brand names, Capramol Analogs

Capramol Brand Names Mixture

  • No information avaliable

Capramol Chemical_Formula


Capramol RX_link

Capramol fda sheet

Capramol FDA

Capramol msds (material safety sheet)

Capramol MSDS

Capramol Synthesis Reference

No information avaliable

Capramol Molecular Weight

131.173 g/mol

Capramol Melting Point

205 oC

Capramol H2O Solubility

5.05E+005 mg/L

Capramol State


Capramol LogP


Capramol Dosage Forms

Solution for injection (containing 250 mg/mL of aminocaproic acid) and tablets (500, 1000mg)

Capramol Indication

For use in the treatment of excessive postoperative bleeding.

Capramol Pharmacology

Aminocaproic acid works as an antifibrinolytic. It is a derivative of the amino acid lysine. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Capramol Absorption

Absorbed rapidly following oral administration. In adults, oral absorption appears to be a zero-order process with an absorption rate of 5.2 g/hr. The mean lag time in absorption is 10 minutes. After a single oral dose of 5 g, absorption was complete (F=1).

Capramol side effects and Toxicity

A few cases of acute overdosage with intravenous administration have been reported. The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death. The intravenous and oral LD50 were 3.0 and 12.0 g/kg respectively in the mouse and 3.2 and 16.4 g/kg respectively in the rat. An intravenous infusion dose of 2.3 g/kg was lethal in the dog.

Capramol Patient Information

Capramol Organisms Affected

Humans and other mammals